Rigel Pharmaceuticals’s recently made public that its CEO, President RODRIGUEZ RAUL R unloaded Company’s shares for reported $34821.0 on Feb 05 ’24. In the deal valued at $1.14 per share,30,545 shares were sold. As a result of this transaction, RODRIGUEZ RAUL R now holds 2,036,629 shares worth roughly $2.57 million.
Then, Santos David A sold 8,918 shares, generating $10,167 in total proceeds. Upon selling the shares at $1.14, the EVP, Chief Commercial Officer now owns 349,093 shares.
Before that, Schorno Dean L sold 7,027 shares. Rigel Pharmaceuticals shares valued at $8,011 were divested by the EVP & Chief Financial Officer at a price of $1.14 per share. As a result of the transaction, Schorno Dean L now holds 402,891 shares, worth roughly $0.51 million.
A number of analysts have revised their coverage, including Citigroup’s analysts, who decreased its forecast for the stock in early June from “a Buy” to “a Neutral”. Piper Sandler also remained covering RIGL and has decreased its forecast on June 08, 2022 with a “Neutral” recommendation from previously “an Overweight” rating. Cantor Fitzgerald revised its rating on June 08, 2022. It rated RIGL as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of RIGL
On Monday, Rigel Pharmaceuticals [NASDAQ:RIGL] saw its stock fall -2.33% to $1.26. Over the last five days, the stock has lost -5.97%. Rigel Pharmaceuticals shares have fallen nearly -13.10% since the year began. Nevertheless, the stocks have risen 5.88% over the past one year. While a 52-week high of $1.96 was reached on 03/06/24, a 52-week low of $0.71 was recorded on 02/08/24. SMA at 50 days reached $1.3388, while 200 days put it at $1.2029. A total of 6.36 million shares were traded, compared to the trading of 0.55 million shares in the previous session.
Levels Of Support And Resistance For RIGL Stock
The 24-hour chart illustrates a support level at 1.2150, which if violated will result in even more drops to 1.1700. On the upside, there is a resistance level at 1.3100. A further resistance level may holdings at 1.3600. The Relative Strength Index (RSI) on the 14-day chart is 38.83, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1007, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 74.24%. Stochastics %K at 31.82% indicates the stock is a holding.
How much short interest is there in Rigel Pharmaceuticals?
A steep rise in short interest was recorded in Rigel Pharmaceuticals stocks on Mar 15, 2024, growing by 1.44 million shares to a total of 4.94 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 3.5 million shares. There was a rise of 29.15%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 2.86% of the overall stock float, the days-to-cover ratio (short ratio) rose to 3.16.
The most recent change occurred on March 23, 2022 when B. Riley Securities began covering the stock and recommended ‘”a Neutral”‘ rating along with a $4 price target.
